[1] L. Rosenwasser, New insights into the pathophysiology of allergic rhinitis, Allergy
Asthma Proc. 28 (2007) 10-15. https://doi.org/10.2500/aap.2007.28.2977.
[2] D. Adamko, P. Lacy, R. Moqbel, Eosinophil function in allergic inflammation: from bone
marrow to tissue response, Curr. Allergy Asthma Rep. 4 (2004) 149-158.
https://doi.org/10.1007/s11882-004-0061-x.
[3] K. Hosoki, I. Boldogh, S. Sur, Innate responses to pollen allergens, Curr. Opin. Allergy
Clin. Immunol. 15 (2015) 79-88. https://doi.org/10.1097/ACI.0000000000000136.
[4] K. Hosoki, T. Itazawa, I. Boldogh, et al., Neutrophil recruitment by allergens contribute to
allergic sensitization and allergic inflammation, Curr. Opin. Allergy Clin. Immunol. 16 (2016)
45-50. https://doi.org/10.1097/ACI.0000000000000231.
[5] T.N. Mayadas, X. Cullere, C.A. Lowell, The multifaceted functions of neutrophils, Annu.
Rev. Pathol. 9 (2014) 181-218. https://doi.org/10.1146/annurev-pathol-020712-164023.
[6] G. Christoffersson, M. Phillipson, The neutrophil: one cell on many missions or many
cells with different agendas?, Cell Tissue Res. 371 (2018) 415-423.
https://doi.org/10.1007/s00441-017-2780-z.
13
[7] C. Engblom, C. Pfirschke, R. Zilionis, et al., Osteoblasts remotely supply lung tumors
with cancer-promoting SiglecFhigh neutrophils, Science 358 (2017).
https://doi.org/10.1126/science.aal5081.
[8] D. Nagakubo, O. Yoshie, T. Hirata, Upregulated CCL28 expression in the nasal mucosa in
experimental allergic rhinitis: Implication for CD4+ memory T cell recruitment, Cell.
Immunol. 302 (2016) 58-62. https://doi.org/10.1016/j.cellimm.2016.02.001.
[9] M.A. Rodriguez-Monroy, S. Rojas-Hernandez, L. Moreno-Fierros, Phenotypic and
functional differences between lymphocytes from NALT and nasal passages of mice, Scand. J.
Immunol. 65 (2007) 276-288. https://doi.org/10.1111/j.1365-3083.2006.01898.x.
[10] M. Costalonga, P.P. Cleary, L.A. Fischer, et al., Intranasal bacteria induce Th1 but not
Treg or Th2, Mucosal Immunol. 2 (2009) 85-95. https://doi.org/10.1038/mi.2008.67.
[11] W.W. Stevens, T.S. Kim, L.M. Pujanauski, et al., Detection and quantitation of
eosinophils in the murine respiratory tract by flow cytometry, J. Immunol. Methods 327
(2007) 63-74. https://doi.org/10.1016/j.jim.2007.07.011.
[12] J.Q. Zhang, B. Biedermann, L. Nitschke, et al., The murine inhibitory receptor
mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is
restricted to eosinophils, Eur. J. Immunol. 34 (2004) 1175-1184.
https://doi.org/10.1002/eji.200324723.
[13] J.A. Hernandez, S.W. Aldred, J.R. Bruce, et al., "Botryoid" nuclei in neutrophils of
patients with heatstroke, Lancet 2 (1980) 642-643.
https://doi.org/10.1016/s0140-6736(80)90307-4.
[14] M.B. Boutilier, N.M. Hardy, R.O. Saffos, Botryoid nuclei in neutrophils of patients with
heatstroke, Lancet 1 (1981) 53. https://doi.org/10.1016/s0140-6736(81)90168-9.
[15] H. Biermann, B. Pietz, R. Dreier, et al., Murine leukocytes with ring-shaped nuclei
include granulocytes, monocytes, and their precursors, J. Leukoc. Biol. 65 (1999) 217-231.
14
https://doi.org/10.1002/jlb.65.2.217.
[16] B. Norberg, Cytoplasmic microtubules and radial-segmented nuclei (Rieder cells).
Ultrastructural studies, Scand. J. Haematol. 7 (1970) 445-454.
https://doi.org/10.1111/j.1600-0609.1970.tb01930.x.
[17] K.A. Neftel, O.M. Muller, Heat-induced radial segmentation of leucocyte nuclei: a
non-specific phenomenon accompanying inflammatory and necrotizing diseases, Br. J.
Haematol. 48 (1981) 377-382. https://doi.org/10.1111/j.1365-2141.1981.tb02729.x.
[18] A. Fujimi, Y. Ikeda, K. Ono, et al., Botryoid nuclei of neutrophils and monocytes in
autoimmune limbic encephalitis, Int. J. Hematol. 95 (2012) 329-330.
https://doi.org/10.1007/s12185-012-1042-9.
[19] M. Fumi, Y. Pancione, S. Sale, et al., Botryoid nuclei resulting from cocaine abuse, Am. J.
Hematol. 92 (2017) 1260-1261. https://doi.org/10.1002/ajh.24769.
[20] A. Woodfin, M. Beyrau, M.B. Voisin, et al., ICAM-1-expressing neutrophils exhibit
enhanced effector functions in murine models of endotoxemia, Blood 127 (2016) 898-907.
https://doi.org/10.1182/blood-2015-08-664995.
[21] J. Pillay, V.M. Kamp, E. van Hoffen, et al., A subset of neutrophils in human systemic
inflammation inhibits T cell responses through Mac-1, J. Clin. Invest. 122 (2012) 327-336.
https://doi.org/10.1172/JCI57990.
[22] T. Tak, P. Wijten, M. Heeres, et al., Human CD62L(dim) neutrophils identified as a
separate subset by proteome profiling and in vivo pulse-chase labeling, Blood 129 (2017)
3476-3485. https://doi.org/10.1182/blood-2016-07-727669.
[23] J. Arebro, S. Ekstedt, E. Hjalmarsson, et al., A possible role for neutrophils in allergic
rhinitis revealed after cellular subclassification, Sci. Rep. 7 (2017) 43568.
https://doi.org/10.1038/srep43568.
[24] G. Zhou, L. Yu, L. Fang, et al., CD177+ neutrophils as functionally activated neutrophils
15
negatively regulate IBD, Gut 67 (2018) 1052-1063.
https://doi.org/10.1136/gutjnl-2016-313535.
Figure legends
Fig. 1.
Two neutrophil subsets are observed in the nasal mucosa. (A) Expression of Ly-6G,
Siglec-F, and CD11c in CD45+ cells in the nasal mucosa from PBS- or OVA-challenged mice.
Gate I, SSChiLy-6GloSiglec-F+CD11clo cells (eosinophils); gate II, Ly-6GhiSiglec-F−CD11c−
cells (conventional Siglec-F− neutrophils); and gate III, Ly-6GhiSiglec-F+CD11c+ cells
(Siglec-F+ neutrophils). (B) May–Grünwald–Giemsa staining of sorted cells in gates I, II, and
III shown in (A). Scale bar, 10 µm. (C) Expression of Ly-6G, Siglec-F, and CD11c in CD45+
cells in the blood from PBS- or OVA-challenged mice. (D) May–Grünwald–Giemsa staining
of sorted cells in gates I and II shown in (C). Scale bar, 10 µm. (E) Expression of Siglec-F and
CD11c in Ly-6Ghi neutrophils in the NALT, CLN, and spleen from PBS- or OVA-challenged
mice. (F) The number of eosinophils (I), Siglec-F− neutrophils (II), and Siglec-F+ neutrophils
(III) in the nasal mucosa from PBS- or OVA-challenged mice. Data (mean ± SEM) represent
the results from three mice per group. *p < 0.05, **p < 0.01.
Fig. 2.
Siglec-F+ neutrophils are located in the nasal lamina propria. Immunofluorescence
staining of nasal mucosa sections (A) and NALT and spleen sections (B) from PBS- or
OVA-challenged mice. Frozen sections were stained for Ly-6G (red), Siglec-F (green), and
DAPI (blue). Arrowheads indicate cells co-expressing Ly-6G and Siglec-F. Squares in the
images on the left in each panel correspond to the images on the right. Scale bars, 50 µm (left
images) and 10 µm (right images).
Fig. 3.
Siglec-F+ neutrophils exhibit an activated phenotype. (A) Expression of
16
representative adhesion molecules in eosinophils (I), Siglec-F− neutrophils (II), and Siglec-F+
neutrophils (III) in the nasal mucosa from PBS- or OVA-challenged mice. Representative
staining results with mAbs to indicated adhesion molecules (open graphs) and isotype
controls (shaded graphs) are shown. (B) Quantitative analysis of expression of representative
adhesion molecules. Data (mean ± SEM) are expressed as the mean fluorescence intensity
(MFI) and represent the results from three mice per group. *p < 0.05, **p < 0.01, ***p <
0.001. (C) Expression of representative chemokine receptors in eosinophils (I), Siglec-F−
neutrophils (II), and Siglec-F+ neutrophils (III) in the nasal mucosa from PBS- or
OVA-challenged mice. Representative staining results with mAbs to indicated chemokine
receptors (open graphs) and isotype controls (shaded graphs) are shown.
Fig. 4.
Siglec-F+ neutrophils exhibit enhanced effector functions. (A) ROS production in
eosinophils (I), Siglec-F− neutrophils (II), and Siglec-F+ neutrophils (III) in the nasal mucosa
from OVA-challenged mice. Data (mean ± SEM) are expressed as the MFI increase calculated
by subtracting the average of MFI of unstimulated cells from the MFI of LPS-stimulated cells
and represent the results from four mice. (B) Phagocytic activity of eosinophils (I), Siglec-F−
neutrophils (II), and Siglec-F+ neutrophils (III) in the nasal mucosa from PBS- or
OVA-challenged mice. Representative flow cytometry histograms of E. coli uptake are shown.
(C) Quantitative analysis of phagocytic activity. Data (mean ± SEM) are expressed as the MFI
and represent the results from three mice per group. *p < 0.05. (D) Expression of Siglec-F,
CD11c, and CD54 in Siglec-F– neutrophils stimulated with or without LPS. Data (mean ±
SEM) are expressed as the MFI and represent the results from three mice per group. *p < 0.05,
**p < 0.01, ***p < 0.001.
17
Figure 1
Nasal mucosa
SSC
II
60.2%
CD11c
III
0.06%
PBS
8.6%
70.4%
II
95.5%
3.4%
Siglec-F
OVA
Ly-6G
5.5%
III
0.9%
3.8%
SSC
74.4%
II
91.0%
CD11c
NALT
PBS
III
2.6%
CLN
Spleen
III
4.0%
III
0.05%
II
94.7%
II
75.7%
OVA
Siglec-F
III
0.0%
II
93.4%
III
1.8%
II
85.1%
III
0.11%
II
82.5%
II
93.2%
CD11c
Nasal mucosa
Cell number
400000
II
OVA
98.5%
Blood
III
20.6%
Siglec-F
OVA
Ly-6G
52.3%
II
PBS
II
73.6%
7.0%
**
II
200000
III
20000
300000
150000
15000
200000
100000
10000
100000
50000
5000
PBS OVA
PBS
PBS
75.9%
12.3%
III
14.2%
27.3%
PBS OVA
PBS OVA
OVA
III
Ly-6G/Siglec-F
DIC
Ly-6G/Siglec-F
Ly-6G/Siglec-F
NALT
DIC
DIC
PBS
Ly-6G/Siglec-F
Ly-6G/Siglec-F
DIC
Nasal mucosa
DIC
OVA
Ly-6G/Siglec-F
PBS
DIC
OVA
Figure 2
Spleen
Figure 3
CD11a
PBS
CD11b
OVA
PBS
CD18
OVA
PBS
OVA
PBS
CD54
OVA
PBS
OVA
CD54
***
***
***
II
III
PBS
CD62L
CD29
CD49d
PBS
OVA
OVA
II
III
CD11a
MFI
20000
CD11b
***
CD18
40000
15000
30000
10000
20000
5000
10000
10000
***
1500
8000
1000
6000
4000
II
III
CD49d
MFI
3000
**
6000
500
2000
II
III
CD29
II
III
II
III
CD62L
4000
PBS
OVA
***
3000
4000
2000
2000
2000
1000
1000
II
III
CCR1
PBS
II
III
OVA
II
III
CCR2
PBS
II
III
CCR3
OVA
PBS
OVA
CXCR2
PBS
OVA
Figure 4
3000
MFI
2000
1000
-1000
-2000
II
III
37ºC
PBS
On ice
OVA
PBS
OVA
II
III
MFI
40000
30000
20000
20000
PBS
OVA
15000
10000
5000
II
Siglec-F
1500
on ice
37ºC
on ice
37ºC
37ºC
on ice
III
CD11c
800
CD54
2500
**
2000
400
MFI
1000
MFI
MFI
600
1500
1000
500
200
500
***
LPS−
LPS+
Supplementary Figure
Fig. S1. Siglec-F+ neutrophils are barely observed in the small intestine. Expression of
Ly-6G, Siglec-F, and CD11c in CD45+ cells in the small intestine from PBS- or
OVA-challenged mice is shown.
...